KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $12.37 $15.59 Friday, 26th Apr 2024 URGN stock ended at $14.15. This is 2.39% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 4.60% from a day low at $13.69 to a day high of $14.32.
90 days $12.37 $19.87
52 weeks $8.69 $24.13

Historical UroGen Pharma Ltd prices

Date Open High Low Close Volume
Jul 12, 2023 $9.61 $9.80 $9.11 $9.60 286 843
Jul 11, 2023 $11.10 $11.10 $9.46 $9.58 313 252
Jul 10, 2023 $11.65 $11.98 $10.95 $11.12 211 532
Jul 07, 2023 $11.23 $11.77 $11.04 $11.74 152 448
Jul 06, 2023 $10.64 $11.19 $10.45 $11.18 168 237
Jul 05, 2023 $10.11 $10.70 $10.11 $10.64 150 380
Jul 03, 2023 $10.35 $10.42 $10.00 $10.11 90 496
Jun 30, 2023 $10.67 $10.89 $10.33 $10.35 158 067
Jun 29, 2023 $10.34 $10.80 $10.17 $10.74 98 227
Jun 28, 2023 $10.35 $10.51 $10.08 $10.42 169 200
Jun 27, 2023 $10.99 $10.99 $10.40 $10.42 162 055
Jun 26, 2023 $11.46 $11.50 $10.33 $11.03 443 152
Jun 23, 2023 $11.70 $12.02 $11.05 $11.46 2 110 082
Jun 22, 2023 $11.83 $12.06 $11.70 $11.92 198 317
Jun 21, 2023 $11.50 $12.20 $11.39 $11.98 248 229
Jun 20, 2023 $12.30 $12.30 $11.62 $11.69 245 251
Jun 16, 2023 $12.21 $12.49 $11.54 $12.00 195 008
Jun 15, 2023 $12.49 $13.17 $11.89 $12.29 133 503
Jun 14, 2023 $12.50 $13.10 $12.44 $12.49 140 682
Jun 13, 2023 $11.89 $12.77 $11.89 $12.34 220 857
Jun 12, 2023 $11.81 $12.41 $11.52 $12.01 198 657
Jun 09, 2023 $10.99 $11.75 $10.78 $11.65 129 559
Jun 08, 2023 $10.70 $11.15 $10.45 $11.06 111 090
Jun 07, 2023 $10.53 $10.68 $10.26 $10.62 186 575
Jun 06, 2023 $9.59 $10.80 $9.55 $10.49 118 612
Click to get the best stock tips daily for free!

About UroGen Pharma Ltd

UroGen Pharma Ltd UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102, which is in Phase III clinical trials for the treatment of several forms... URGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT